Bunolol

• CAT Number: I023808
• CAS Number: 27591-01-1
• Molecular Formula: C17H25NO3
• Molecular Weight: 291.39
• Purity: 98%
• Synonyms: Bunolol; BRN 1887243; BRN-1887243; BRN1887243
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4℃ for short term (days to weeks) or -20℃ for long term (months to years).
• IUPAC Name: 5-[3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydro-2H-naphthalen-1-one
• InChI: InChI=1S/C17H25NO3/c1-17(2,3)18-10-12(19)11-21-16-9-5-6-13-14(16)7-4-8-15(13)20/h5-6,9,12,18-19H,4,7-8,10-11H2,1-3H3
• InChIKey: IXHBTMCLRNMKHZ-UHFFFAOYSA-N
• SMILES: CC(C)(C)NCC(COC1=CC=CC2=C1CCCC2=O)O

Bunolol (Cat.No:I023808) is a non-selective beta-blocker used to treat high blood pressure and glaucoma. It works by blocking the beta-adrenergic receptors in the body, which reduces the effects of stress hormones such as adrenaline. This leads to a decrease in heart rate, blood pressure, and intraocular pressure. Bunolol is available in oral and ophthalmic formulations, and its use should be monitored by a healthcare professional due to potential side effects.

Reference

1: Leinweber FJ, Szpiech JM, Di Carlo FJ. l-bunolol metabolites in human urine. Pharmacology. 1978;16(2):70-7. PubMed PMID: 339235.
2: Watson DG, Midgley JM, McGhee CN. Determination of (-)-bunolol and its metabolite, dihydro-(-)-bunolol, in human aqueous humour by gas chromatography-negative ion chemical ionisation mass spectrometry. J Chromatogr. 1991 Nov 15;571(1-2):101-8. PubMed PMID: 1810939.
3: Leinweber FJ, Szpiech JM, Di Carlo FJ. l-Bunolol metabolism in rats: identification of urinary metabolites. J Pharm Sci. 1978 Jan;67(1):129-31. PubMed PMID: 338886.
4: Lin L, Wang Y, Chen Y, Liu M. Bradyarrhythmias secondary to topical levobunolol hydrochloride solution. Clin Interv Aging. 2014 Oct 13;9:1741-5. doi: 10.2147/CIA.S69420. eCollection 2014. PubMed PMID: 25342892; PubMed Central PMCID: PMC4206249.
5: Commarato MA, Giardino EC, Kopia GA, Kaplan HR. Levo-bunolol and propranolol: further evaluation of oral beta-blocking activity in conscious dogs. Arch Int Pharmacodyn Ther. 1977 Apr;226(2):205-13. PubMed PMID: 327960.
6: Di Carlo FJ, Leinweber FJ, Szpiech JM, Davidson IW. Metabolism of l-bunolol. Clin Pharmacol Ther. 1977 Dec;22(6):858-63. PubMed PMID: 336256.
7: Horcajada-Reales C, Rodríguez-Soria VJ, Suárez-Fernández R. Allergic contact dermatitis caused by timolol with cross-sensitivity to levobunolol. Contact Dermatitis. 2015 Dec;73(6):368-9. doi: 10.1111/cod.12448. Epub 2015 Jul 31. PubMed PMID: 26227808.
8: Kochar B, Shan SJ, Anand G, Zinreich SJ, Gelber AC. Totally one-sided: painless unilateral proptosis. Am J Med. 2015 Apr;128(4):361-3. doi: 10.1016/j.amjmed.2014.12.005. Epub 2015 Jan 5. PubMed PMID: 25572713.
9: Chen CC, Anderson J, Shackleton M, Attard J. The disposition of bunolol in the rabbit eye. J Ocul Pharmacol. 1987 Summer;3(2):149-57. PubMed PMID: 3332677.
10: Gupta RS, Khanna NK, Madan BR. Propranolol-bunolol and phencarbamide in chloroform-induced ventricular fibrillation in mice. Arch Int Pharmacodyn Ther. 1973 Jun;203(2):265-7. PubMed PMID: 4582610.
11: Schwender CF, Pike RE, Shavel J Jr. Derivatives of 3,4-dihydro-1(2H)-naphthalenone as beta-adrenergic blocking agents. 2. Aromatic-substituted analogs of bunolol. J Med Chem. 1973 Mar;16(3):254-7. PubMed PMID: 4147388.
12: Leinweber FJ, Greenough RC, Schwender CF, Kaplan HR, Di Carlo FJ. Bunolol metabolism by cell-free preparations of human liver: biosynthesis of dihydrobunolol. Xenobiotica. 1972 Mar;2(2):191-202. PubMed PMID: 4560367.
13: Kaplan HR, Barker JW, Dugan D, Fox J, Giardino E. Antiarrhythmic and general cardiovascular activity of the N,N-dimethylquaternary ammonium derivative of bunolol. Arch Int Pharmacodyn Ther. 1974 Jan;207(1):28-43. PubMed PMID: 4151048.
14: Li F, Cooper SF, Côté M, Ayotte C. Determination of the enantiomers of bunolol in human urine by high-performance liquid chromatography on a chiral AGP stationary phase and identification of their metabolites by gas chromatography-mass spectrometry. J Chromatogr B Biomed Appl. 1994 Oct 14;660(2):327-39. PubMed PMID: 7866523.
15: Chen CC, Koda RT, Shackleton M. The ocular distribution of bunolol in the eyes of albino and pigmented rabbits. J Ocul Pharmacol. 1988 Spring;4(1):37-42. PubMed PMID: 3049859.
16: Singh KP. Influence of beta-adrenoceptor antagonists on spontaneous rate and on force of contraction of isolated rabbit atria. Indian J Physiol Pharmacol. 1983 Oct-Dec;27(4):311-6. PubMed PMID: 6146567.
17: Leinweber FJ, Greenough RC, Di Carlo FJ. Bunolol metabolism by dogs: identification of basic metabolites and their conjugates. J Pharm Sci. 1977 Nov;66(11):1570-5. PubMed PMID: 335043.
18: Khanna NK, Gupta RS, Mathur AK, Gupta K. Neuropharmacological actions of two new adrenergic beta-receptor antagonists, bunolol and H 64-52. Jpn J Pharmacol. 1972 Apr;22(2):262-4. PubMed PMID: 4403582.
19: Kaplan HR, Commarato MA. Relative beta adrenergic receptor blocking activity in dogs after intravenous and intraportal vein administration: bunolol, propranolol, their levo isomers and sotalol. J Pharmacol Exp Ther. 1973 May;185(2):395-405. PubMed PMID: 4145046.
20: Antonaccio MJ, High J, DeForrest JM, Sybertz E. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function. J Pharmacol Exp Ther. 1986 Jul;238(1):378-87. PubMed PMID: 2873238.